LENSAR, Inc. — Company profile
Healthcare · Medical Devices · United States
Last price 5.8 USD (Oct 30, 2026, 3:27 PM EDT) · Market cap 71.26M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Details
| Name | LENSAR, Inc. |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 150 |
| Founded | 2004 |
| Ceo | Nicholas Curtis |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US52634L1089 |
| Cusip | 52634L108 |
| Cik | 1320350 |
| Sic | 3841 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Nicholas T. Curtis | President, Chief Executive Officer and Director |
| Alan B. Connaughton | Chief Operating Officer |
| Michael A. Rossi | Interim Chief Financial Officer and Principal Financial Officer and Secretary |
| Kendra W. Wong | Principal Accounting Officer |
Contact
| Address | 2800 Discovery Drive, Orlando, Florida 32826, United States |
| Phone | 888 536 7271 |
| Website | https://www.lensar.com |